investorscraft@gmail.com

Intrinsic value of Aflac Incorporated (AFL)

Previous Close$59.43
Intrinsic Value
Upside potential
Previous Close
$59.43
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh51.48 

The original valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %-0.2NaN
Revenue, $22106NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m16784NaN
Operating income, $m5322NaN
EBITDA, $m6492NaN
Interest expense (income), $mNaN
Earnings before tax, $m5322NaN
Tax expense, $m997NaN
Net income, $m4325NaN

BALANCE SHEET

Cash and short-term investments, $m5051NaN
Total assets, $m164553NaN
Adjusted assets (=assets-cash), $m159502NaN
Average production assets, $m578NaN
Working capital, $m-99328NaN
Total debt, $m7915NaN
Total liabilities, $m131300NaN
Total equity, $m33253NaN
Debt-to-equity ratio0.238NaN
Adjusted equity ratio0.177NaN

CASH FLOW

Net income, $m4325NaN
Depreciation, amort., depletion, $m1170NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m5051NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-10NaN
Free cash flow, $m5061NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m-99328
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount